🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Albuminuria: A Marker of Adverse Kidney Outcomes in Heart Failure Individuals with moderate albuminuria and HF are at high risk for CKD progression, particularly those with reduced eGFR sciencedirect.com/science/articl…

Learned quite a lot about interactions, thresholds, and synergistic effects from @ashunephro in this analysis of albuminuria, heart failure, and CKD progression. Our findings emphasize albuminuria as a key biomarker for CKM health. 🫘 #NephTwitter American Society of Nephrology

Cumulative Incidence of Mortality (CKM) syndrome stage 1 to stage 4 are associated with a graded risk of cardiovascular mortality in a nationally representative sample of U.S. adults. bit.ly/JASN0637 #ASNJASN

Contribution of the GFR slope to the kidney hierarchical composite endpoint Kidney International sciencedirect.com/science/articl…

Thank you ASN Publications for highlighting our study on CKM syndrome #CKM Sophie Claudel, MD

Thank you Nature Reviews Nephrology for highlighting our study nature.com/articles/s4158… “Cumulative Incidence of Mortality Associated with Cardiovascular-Kidney-Metabolic Syndrome” published in #JASN ASN Publications Sophie Claudel, MD Original paper: journals.lww.com/jasn/fulltext/…

Genetic Testing in Biopsy-Confirmed Kidney Disease kidneymedicinejournal.org/article/S2590-…

Congratulations to BU/BMC Section of Nephrology team for this important piece. Insa Schmidt, Sushrut Waikar Ashish Verma, MD Sophie Claudel, MD Laurence H Beck, Jr 🎊🎉👋

Dr. Jaberi Aala Jaberi gives a fantastic lecture on kidney #ultrasound at the #NKFclinicals #POCUS precourse.

Pre course Nephrology POCUS@NKF Boston, NephroPOCUS Nathaniel Reisinger , great working working with you all

Excited to share our comprehensive review “ Cardiovascular-Kidney-Metabolic Health: Definition, Staging, Risk Assessment, and Therapeutic Considerations” in CardiologyClinics Sophie Claudel, MD BU/BMC Section of Nephrology Thank you Janani Rangaswami for the opportunity. kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

🔥 #CONFIDENCE closed out & selected as LBCT to headline #ERA25, led by #ProfRajivAgarwal Largest RCT to test combination #SGLT2i empagliflozin & #nsMRA finerenone Will 1+1 = 2? Baseline: academic.oup.com/ndt/advance-ar… Design: academic.oup.com/ndt/article/38… See you in Vienna 🇦🇹 ERA - European Renal Association

*New* 2025 JCS/JHFS Japanese Guidelines Prevention of #HF #SGLT2i class I (4 T2D & 4 CKD RCTs) #nsMRA class I (FIDELIO FIGARO) Treatment of #HFpEF #SGLT2i class I (DELIVER EMPEROR SOLOIST) #nsMRA class IIa (FINEARTS) #sMRA class IIb (TOPCAT) #ARNI/#ARB class IIb (PARAGON/CHARM)

“What’s Old is New Again!” - C. Michael Gibson MD The MR / aldosterone axis remains in central focus for the *treatment* and now *prevention* of heart and kidney disease in 2025

.American Society of Nephrology President Prabir Roy Chaudhury shares why he believes nephrology is a special field, and the surprising reasons why he chose the specialty nearly 30 years ago. bit.ly/KN1705-03 #ASNKidneyNews

More than 50% reduction in uacr with combo and about 30% with each component that is empagliflozin and finerenone. Time to consider simultaneous initiation of combination therapy in ckd and t2d as in hfref and stage 2 hypertension.

Sex-specific ACR thresholds may improve our ability to identify patients at risk of adverse cardiovascular and kidney outcomes. Read the latest Letter to the Editor by Sophie Claudel, Sushrut Waikar & Ashish Verma, MD: buff.ly/dl6SK5I #LabMed #PathTwitter #JALM #ClinChem

Adrenal Insufficiency

This narrative, state-of-the-art review discusses the role of albuminuria in CKM conditions and identifies potential pathways linking albuminuria to adverse cardiovascular outcomes. This review highlights the importance of testing for albuminuria in cardiovascular practice and

🎓Huge congratulations to our graduating BU/BMC Section of Nephrology Nephrology Fellows! Your compassionate care and excellence have left a lasting impact on our patients & Boston Medical Center Boston U Chobanian & Avedisian School of Medicine. We can’t wait to see the incredible things you’ll do next! Joyita Bharati MikeBaldino